CATX SG&A Expense Growth
Perspective Therapeutics Inc · SG&A Expense Growth
CATX SG&A Expense Growth
Latest reported13.60%period ending
CATX FY SG&A Growth (YoY) (0.00% → 13.60%)
Latest values, visible window
High-resolution chart · PNG
CATX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.6024% | |
| 26.3435% | |
| 125.2352% | |
| -0.7745% | |
| 32.1694% | |
| -5.5121% | |
| 10.1591% | |
| 0.381% | |
| 9.5857% | |
| 21.1816% | |
| 32.1585% | |
| 4.4552% | |
| 3.6939% | |
| 0.5525% | |
| -2.3112% | |
| -16.8118% | |
| -14.8267% | |
| -29.2687% | |
| -12.1307% | |
| 68.5628% | |
| 91.3619% | |
| 13,427.2159% | |
| 150.8175% | |
| 0% | |
| 0% | |
| -100% | |
| -93.0008% | |
| -79.9632% | |
| -57.2204% | |
| 108.2019% | |
| 1.3098% | |
| 0% |